论文部分内容阅读
目的主要针对肾癌患者应用后腹腔镜肾癌根治术治疗的临床疗效进行观察。方法抽取第四军医大学西京医院泌尿外科于2010-06-2015-06收治的90例肾癌患者作为主要研究对象。采取随机数字表法将所有患者划分为观察组和对照组。其中,对照组患者给予其常规的开放性胃癌根治术治疗,而观察组则给予其后腹腔镜肾癌根治术进行治疗。对比两组患者的临床疗效、出血量、住院时间以及感染情况等多项指标。结果经治疗,观察组患者手术时间、出血量以及住院时间均显著低于对照组,两组数据差异明显(P<0.05),差异有统计学意义。且观察组患者术后肺感染、切口感染以及肠损伤等并发症发生率显著低于对照组,组间数据差异明显(P<0.05),差异有统计学意义。此外,观察组1a,2a,3a生存率要显著高于对照组(P<0.05)。结论经对比发现,采用后腹腔镜肾癌根治术治疗肾癌,具有显著的优点,其手术时间更短、创伤较小,并发症发生率低,且预后效果良好等。因此,值得在临床中推广及使用。
Objective To observe the clinical effect of retroperitoneal laparoscopic radical nephrectomy in patients with renal cell carcinoma. Methods Totally 90 patients with renal cell carcinoma admitted to Department of Urology, Xijing Hospital, Fourth Military Medical University from June 2010 to June 2015 were selected as the main study subjects. All patients were divided into observation group and control group by random number table method. Among them, the control group of patients given its conventional open radical gastrectomy, while the observation group was given laparoscopic radical nephrectomy for treatment. Comparison of two groups of patients clinical efficacy, bleeding, hospital stay and infection and many other indicators. Results After treatment, the operation time, blood loss and hospitalization time in the observation group were significantly lower than those in the control group. There was significant difference between the two groups (P <0.05), the difference was statistically significant. The complication rates of postoperative lung infection, incision infection and intestinal injury in the observation group were significantly lower than those in the control group (P <0.05). The difference was statistically significant. In addition, the survival rates of observation group 1a, 2a, 3a were significantly higher than those of the control group (P <0.05). Conclusions It is found by comparison that the use of retroperitoneal laparoscopic radical nephrectomy in the treatment of renal cell carcinoma has the significant advantages of shorter operation time, less trauma, lower complication rate and good prognosis. Therefore, it is worth in the clinical promotion and use.